News for Jiangsu Hengrui Medicine Co., Ltd. (600276.SS)

The allogeneic hematopoietic stem cell transplant market is expected to experience significant growth in the coming years, driven by advances in...

Renal cancer, also known as kidney cancer, is a disease where malignant (cancer) cells form in the tissues of the kidneys. Smoking, obesity, hypertension,...

The stem cell market is experiencing positive growth due to several factors, including the increasing prevalence of chronic diseases, the need for drug...

The pancreatic cancer market is expected to show positive growth, mainly attributed to the increasing incident cases and also, the launch of upcoming...

In this article, we discuss the 25 richest billionaires in healthcare industry.

US PARP inhibitor market to grow steadily at 11.2%. Personalized medicine & strong R&D fuel innovation despite regulatory hurdles. ...

“PARP Inhibitor Market” from 2024-2034 with covered segments (PARP Inhibitor Market, By Drug (Lynparza, Niraparib, Rucaparib and Others), By Indication...

The Inhalation Anaesthesia Market is poised for significant growth due to two key drivers, the increasing number of surgeries globally and the growing...

The hypoparathyroidism market is expected to grow by factors like an increase in the patient pool, and expected entry of emerging therapies....

The escalating occurrences of miscarriages, coupled with a surge in the adoption of advanced technologies, and a notable uptick in product launches and...

The triple-negative breast cancer market is witnessing significant growth and evolution due to increased awareness, technological advancements, therapeutic...

The prevalence of Nasopharyngeal Cancer is increasing globally due to environmental, pathogen-mediated, and genetic factors as well as lifestyle factors,...

/PRNewswire/ -- DelveInsight's Esophageal Cancer Market Insights report includes a comprehensive understanding of current treatment practices, esophageal...

The growing frequency of chronic diseases such as asthma, arthritis, chronic obstructive pulmonary disease (COPD), and others is driving up demand for...

The cervical cancer market is expected to grow due to factors like an increase in the patient pool, rising awareness of the disease, an increase in...

The prevalence of thrombocytopenia has been rising over the past few years, which prompts the growing demand for treatment options. The increasing...

Key Takeaways: Hengrui Pharma has named the former top executive of the smaller CStone as its new chief strategy officer, hoping he can help to reverse its recent decline The company has lost four vice general managers since last year, and its stock is down nearly 60% from its high at the end of 2020. By Molly Wen

/PRNewswire/ -- DelveInsight's 'Pancreatic Cancer Pipeline Insight – 2022' report provides comprehensive global coverage of available, marketed, and pipeline...

/PRNewswire/ -- DelveInsight's 'Gastric Cancer Pipeline Insight – 2022' report provides comprehensive global coverage of available, marketed, and pipeline...